Clinical trial · Interventional
Qigong Exercise for Muscles Strength and Quality of Life in Colorectal Cancer Patients Undergoing Chemotherapy
NCT07709429CI-TRIAL-00118285not yet recruitingN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to evaluate therapeutic effect of Qigong for muscle strength and quality of life in colorectal cancer patients undergoing chemotherapy.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Colorectal Cancer | Malignant Colorectal Neoplasm | CURATED_BROADER | 0.80 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Conventional Exercise Program | Other | — | UNRESOLVED |
| Qigong Exercise | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Qigong Exercise + Conventional Exercise Program
- description
- Participants will receive a supervised Baduanjin Qigong exercise program combined with conventional exercises, including pain-free range-of-motion exercises, low-intensity walking, and physical therapy education. The intervention will be conducted three times weekly for 12 weeks under physiotherapist supervision, while participants continue their prescribed chemotherapy and routine medical follow-up.
- interventionNames
- Other: Qigong Exercise
- Other: Conventional Exercise Program
- type
- ACTIVE_COMPARATOR
- label
- Conventional Exercise Program
- description
- Participants in this arm will receive a conventional exercise program consisting of pain-free range-of-motion exercises for the shoulder, elbow, wrist, hip, knee, and ankle joints, low-intensity walking, and physical therapy education to maintain daily activities. The intervention will be administered for 12 weeks, with three sessions per week. Participants will continue their prescribed chemotherapy and routine outpatient medical follow-up throughout the study and will not participate in any additional structured exercise program during the intervention period.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 35 Years
- Maximum age
- 55 Years
Show eligibility criteria text
Inclusion Criteria: * Age ranges between 35 and 55 years. * Male \& female patients will participate in the study. * All patients with colorectal cancer undergoing chemotherapy. * All patients enrolled to the study will have their informed consent. * The patients will be instructed to report any side effects during the management. Exclusion Criteria: * Presence Patients with psychological disturbance or mental illness. * Cardiopulmonary disease. * Hypotensive patients. * Nerve, muscle, or joint disease, or other malignant tumors affecting movement. * Autoimmune disease.
References
Publications (0)
Data not yet available
No reference posted for this study.